DIE CHEMOTHERAPIE MALIGNER OVARIALTUMOREN. = LA CHIMIOTHERAPIE DES TUMEURS MALIGNES DE L'OVAIREPICKEL H; LAHOUSEN M.1977; WIEN. MED. WSCHR.; OESTERR.; DA. 1977; VOL. 127; NO 17; PP. 539-541; BIBL. 8 REF.Article

COMPARISON OF ORAL PROSTAGLANDIN E₂ AND INTRAVENOUS OXYTOCIN FOR INDUCTION OF LABOURCICHTENEGGER W; LAHOUSEN M; KRAEMER H et al.1981; GYNECOL. OBSTET. INVEST.; ISSN 0378-7346; CHE; DA. 1981; VOL. 12; NO 4; PP. 197-202; BIBL. 5 REF.Article

THE SIGNIFICANCE OF LYMPHADENECTOMY IN THERAPY OF OVARIAN CARCINOMA = LA SIGNIFICATION DE LA LYMPHADENECTOMIE DANS LE TRAITEMENT DU CANCER DE L'OVAIREBURGHARDT E; PICKEL H; HOLZER E et al.1983; AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY; ISSN 0002-9378; USA; DA. 1983; VOL. 146; NO 1; PP. 111-112; BIBL. 4 REF.; FIGArticle

Prognostic factors and operative treatment of stages IB to IIB cervical cancerBURGHARDT, E; PICKEL, H; HAAS, J et al.American journal of obstetrics and gynecology. 1987, Vol 156, Num 4, pp 988-996, issn 0002-9378Article

Partus nach konservativer Therapie eines Rhabdomyosarkoms der Zervix = Successful pregnancy after conservative treatment of botryoid embryonal rhabdomyosarcoma of the uterine cervix. A case reportREICH, O; LAHOUSEN, M; WINTER, R et al.Geburtshilfe und Frauenheilkunde. 2001, Vol 61, Num 1, pp 39-41, issn 0016-5751Article

Borderlinetumoren des Ovars : Darstellung eines sich entwickelnden Konzeptes = Borderline tumors of the ovary: An evolving conceptREICH, O; LAHOUSEN, M; PICKEL, H et al.Geburtshilfe und Frauenheilkunde. 1999, Vol 59, Num 10, pp 488-494, issn 0016-5751Article

Morphologische Veränderungen der Zervix nach Messerkonisation = Morphologic changes at the uterine cervix after cold-knife conizationREICH, O; LAHOUSEN, M; PICKEL, H et al.Geburtshilfe und Frauenheilkunde. 2000, Vol 60, Num 5, pp 273-275, issn 0016-5751Article

Remission induction with carboplatin-epirubicin-prednimustine followed by consolidation radiotherapy in advanced ovarian cancerPETRU, E; PICKEL, H; HEYDARFADAI, M et al.International journal of clinical pharmacology research. 1992, Vol 12, Num 4, pp 205-207, issn 0251-1649Article

Pelvic lymphadenectomy in operative treatment of ovarian cancerBURGHARDT, E; PICKEL, H; LAHOUSEN, M et al.American journal of obstetrics and gynecology. 1986, Vol 155, Num 2, pp 315-319, issn 0002-9378Article

Prognostic factors in cervical cancerPICKEL, H; HAAS, J; LAHOUSEN, M et al.European journal of obstetrics, gynecology, and reproductive biology. 1997, Vol 71, Num 2, pp 209-213, issn 0301-2115Conference Paper

Patterns of pelvic and paraaortic lymph node involvement in ovarian cancerBURGHARDT, E; GIRARDI, F; LAHOUSEN, M et al.Gynecologic oncology (Print). 1991, Vol 40, Num 2, pp 103-106, issn 0090-8258, 4 p.Article

The predictive value of a combination of tumor markers in monitoring patients with ovarian cancerLAHOUSEN, M; STETTNER, H; PICKEL, H et al.Cancer. 1987, Vol 60, Num 9, pp 2228-2232, issn 0008-543XArticle

Primäres, papilläres seröses Karzinom des Peritoneums; ein Erfahrungsbericht = Experience with primary, serous papillary carcinoma of the peritoneumPETRU, E; HEYDARFADAI, M; PICKEL, H et al.Geburtshilfe und Frauenheilkunde. 1992, Vol 52, Num 9, pp 533-535, issn 0016-5751Article

Expression of oestrogen and progesterone receptors in low-grade endometrial stromal sarcomasREICH, O; REGAUER, S; URDL, W et al.British journal of cancer. 2000, Vol 82, Num 5, pp 1030-1034, issn 0007-0920Article

Combination chemotherapy in radically operated advanced ovarian cancerPETRU, E; PICKEL, H; LAHOUSEN, M et al.Cancer treatment reviews. 1990, Vol 17, Num 2-3, pp 329-334, issn 0305-7372, 6 p.Article

Epoetin alfa in platinum-treated ovarian cancer patients : results of a multinational, multicentre, randomised trialWILKINSON, P. M; ANTONOPOULOS, M; LAHOUSEN, M et al.British journal of cancer. 2006, Vol 94, Num 7, pp 947-954, issn 0007-0920, 8 p.Article

Clear cell carcinoma of the uterine cervix : Pathology and prognosis in surgically treated stage IB-IIB disease in women not exposed in utero to diethylstilbestrolREICH, O; TAMUSSINO, K; LAHOUSEN, M et al.Gynecologic oncology (Print). 2000, Vol 76, Num 3, pp 331-335, issn 0090-8258Article

Consolidation radiotherapy after carboplatin-based chemotherapy in radically operated advanced ovarian cancerPICKEL, H; LAHOUSEN, M; PETRU, E et al.Gynecologic oncology (Print). 1999, Vol 72, Num 2, pp 215-219, issn 0090-8258Article

Selective decrease in serum immunoglobulin G1 : A tissue nonspecific tumor maker detecting early stages of gynecologic malignant disease with high efficiencySCHAUENSTEIN, E; LAHOUSEN, M; WEBLACHER, M et al.Cancer. 1996, Vol 78, Num 3, pp 511-516, issn 0008-543XArticle

Lymphadenectomy in stage I ovarian cancerPETRU, E; LAHOUSEN, M; TAMUSSINO, K et al.American journal of obstetrics and gynecology. 1994, Vol 170, Num 2, pp 656-662, issn 0002-9378Article

Lymphogenous metastasis in the primary carcinoma of the Fallopian tubeKLEIN, M; ROSEN, A; LAHOUSEN, M et al.Gynecologic oncology (Print). 1994, Vol 55, Num 3, pp 336-338, issn 0090-8258, 1Article

Nongenital cancers metastatic to the ovaryPETRU, E; PICKEL, H; HEYDARFADAI, M et al.Gynecologic oncology (Print). 1992, Vol 44, Num 1, pp 83-86, issn 0090-8258Article

Pretherapeutic scalene lymph node biopsy in ovarian cancerPETRU, E; PICKEL, H; TAMUSSINO, K et al.Gynecologic oncology (Print). 1991, Vol 43, Num 3, pp 262-264, issn 0090-8258Article

Tumor progression, histologic grading and DNA-ploidy as predictive factors of lymphogenous metastasis in primary carcinoma of the Fallopian tubeKLEIN, M; GRAF, A.-H; ROSEN, A et al.Cancer letters. 2002, Vol 177, Num 2, pp 209-214, issn 0304-3835Article

Erythropoietin treatment under polychemotherapy in patients with gynecologic malignancies : A prospective, randomized, double-blind placebo-controlled multicenter studyKURZ, C; MARTH, C; WINDBICHLER, G et al.Gynecologic oncology (Print). 1997, Vol 65, Num 3, pp 461-466, issn 0090-8258Article